Back to Trades
Karlin Daniel
Chief Medical OfficerDirectorCIK 0001897618
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 1
- Active
- 2025–2026
Across 9 filings between 2025–2026, Karlin Daniel, Chief Medical Officer, Director, has disclosed $1.1M in transactions — all concentrated in Definium Therapeutics, Inc. (DFTX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.1M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Sep 29 | DFTX Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Officer, Director | Sell | $396.9K |
| Sep 14 | DFTX Definium Therapeutics, Inc. | Karlin Daniel | Insider | Grant | $0 |
| Aug 12 | DFTX Definium Therapeutics, Inc. | Karlin Daniel | Insider | Grant | $0 |
| Jun 26 | DFTX Definium Therapeutics, Inc. | Karlin Daniel | Insider | Sell | $451.9K |
| Jun 22 | DFTX Definium Therapeutics, Inc. | Karlin Daniel | Insider | Grant | $0 |
| Mar 26 | DFTX Definium Therapeutics, Inc. | Karlin Daniel | Insider | Sell | $148.1K |
| Feb 5 | DFTX Definium Therapeutics, Inc. | Karlin Daniel | Insider | Grant | $0 |
| Dec 29 | MNMD Mind Medicine (MindMed) Inc. | Karlin Daniel | Insider | Sell | $73.6K |
| Sep 26 | MNMD Mind Medicine (MindMed) Inc. | Karlin Daniel | Insider | Sell | $75.3K |
9 filings